IMPACCT Working Group Importation of Medicines and Medical Equipment during disease outbreak
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
IMPACCT Working Group
Importation of Medicines
and Medical Equipment
during disease outbreak
© GS1 2021 1
GS1 Competition Law Caution
• GS1 operates under the GS1 Competition Law Caution. Strict compliance with
competition laws is and always has been the policy of GS1.
• The best way to avoid problems is to remember that the purpose of the group
is to enhance the ability of all industry members to compete more efficiently.
• This means:
- There shall be no discussion of prices, allocation of customers, or
products, boycotts, refusals to deal, or market share
- If any participant believes the group is drifting toward impermissible
discussion, the topic shall be tabled until the opinion of counsel can be
obtained.
• The full caution is available via the link below, if you would like to read it in its
entirety: http://www.gs1.org/gs1-anti-trust-caution
•
© GS1 2021
Question (Sophie)
How the global standards can support
the importation of goods?
© GS1 2021
Zoom poll 1: What does GS1 stand for?
1. Global Supply Chain 1;
2. Global Services 1;
3. Global Specifications 1;
4. Global Standards 1
© GS1 2021
Zoom poll 2: What does GS1 do?
1. GS1 is a solution provider;
2. GS1 is a sectoral association;
3. GS1 is a global standard development organisation;
4. GS1 is a donor organisation;
© GS1 2021
GS1 believes in the power of standards to
transform the way we work and live
➢ Everything began with a barcode on 26 June 1974: a packet of chewing-gum is the
first barcoded product to be scanned in a store
➢ Global, neutral, non-profit standard development organisation that brings
efficiency and transparency to the supply chain;NGO to the UN
➢ Standards are proven, open and benefit from collaboration with respected global
companies and local SME’s;
➢ Strong engagement with governments across multiple sector and geographies;
➢ GS1 Global works with Retail, Food, Technical industries, Transport/Logistics and of
course Healthcare
© GS1 2021
GS1: global coverage
The Global Language of Business © GS1 2021 7
GS1 is a global standards organisation
© GS1 2021 8
GS1: global system of standards
© GS1 2021 9
GS1 standards and traceability of healthcare
products
Tracking products across the healthcare supply chain:
- helps to decrease counterfeit healthcare products;
- Increase supply chain efficiency as well as patient safety;
- complies with regulations
Traceability in healthcare enables you to see the movement of drugs,
medical devices, vaccines and PPE across the supply chain.
= Visibility* = What, When, Where & Why
RIGHT RIGHT RIGHT LOW
PRODUCT TIME PLACE COST
© GS1 2021 10GS1 Healthcare in access and humanitarian
aid in the developing world
https://www.youtube.com/watch?v=CI_Ae7JXZKQ
© GS1 2021 11Comment (Géraldine)
There is a need for global harmonisation
in a very challenging global healthcare context
© GS1 2021The need for harmonised Pharmaceutical and
UDI requirements
The legal landscape for traceability of pharmaceutical products and medical devices is
always moving which means long-term compliance is a two-fold challenge.
© GS1 2021Unique identification of pharmaceuticals
= country accepts GS1 Standards
= country requires national ID #
= no input available
© GS1 2021GS1 DataMatrix on pharmaceuticals
© GS1 2021Requirements for medical device identification
© GS1 2021WHO Policy paper on traceability of medical products
This policy paper outlines the features of existing traceability systems and provides
guidance on developing workable traceability regulation. For this purpose, Member States
are encouraged to:
- establish a suitable governance process for their traceability system based on the
analysis of national specificities (e.g. regulatory environment, supply chain management);
- include a costing analysis as well as a sustainability mechanism in their traceability
system planning to prevent costs from negatively impacting patients, government, supply
chain stakeholders, and ultimately, access to medical products;
In particular, this paper refers to the use GS1 global standards for product identification,
production identification, automatic identification, and data capture and data exchange to
reduce set-up and operating system costs and maximize national and international
interoperability.
https://www.who.int/publications/i/item/policy-paper-on-traceability-of-medical-products
published in March 2021
© GS1 2021 17Africa Strategy for Pharmaceutical Traceability
https://www.gs1.org/events/2019/lagos/call-to-action
© GS1 2021 18Last question for Sophie/ Géraldine
How can GS1 support and collaborate
with the IMPACCT working group on this topic?
© GS1 2021What has been done in partnership
with the WCO
Border Procedure
Up to 2015 – now abandoned In 2019
World Customs Organisation (WCO), has
dubbed 2019 as: Warehouse management
“the year of SMART Borders”,
focusing on the swift and smooth cross-
border
movement of goods, people and means
of transport.
GS1 is supporting WCO to improve
border operations,
working with both industry and
government.
© GS1 2021What is currently done in terms of
humanitarian logistics
Border Procedure
Warehouse management
© GS1 2021Future actions to support
IMPACCT working group
• Raising awareness
• Training and education of people
• Supply chain efficiency and integrity
• Fight against counterfeiting and diversion of goods
• Connect with regulatory authorities and
other intergovernmental organisations
Proposal: Facilitation of working group with concrete list of projects
(mapping of countries which are using the SSCC or not; mapping of suppliers using
GS1 or not, etc…)
© GS1 2021Contact Details Géraldine Lissalde-Bonnet Sophie Molle Director Public Policy Senior Manager Healthcare GS1 Global Office, Brussels GS1 Global Office, Brussels E g.lissalde@gs1.org E sophie.molle@gs1.org W www.gs1.org/healthcare
You can also read
